In8Bio (INAB) Current Leases (2021 - 2026)
In8Bio (INAB) recorded Current Leases of $126,000 in Q2 2026, down 68.8% from $404,000 a year earlier and down 33.3% from the prior quarter.
Powered by 
Analysis
In8Bio (INAB) Current Leases (2021 - 2026) Analysis & Trends
At the end of FY2025, In8Bio reported Current Leases of $295,000, down 57.5% from FY2024.
- Annual Current Leases has a four-year compound annual growth rate of -6.9% (FY2021 to FY2025).
- Across earlier years, Current Leases came in at $694,000 in FY2024 (unchanged), $694,000 in FY2023 (+1.8%), $682,000 in FY2022 (+74.0%) and $392,000 in FY2021.
- The Q2 2026 figure is the lowest quarterly Current Leases in data going back to Q2 2021.
- On a year-over-year basis, Current Leases has declined for six consecutive quarters, with an average decline of 38.5% over the last eight quarters.
- Peak year-over-year performance for Current Leases in the last five years was growth of 159.1% in Q3 2023, against a decline of 68.8% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $189,000 (Q1 2026), $295,000 (Q4 2025) and $343,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 274.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -2.32 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | In8Bio | 25.89 Mn | 25.89 Mn | - | 126,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 126,000.00 |
| Mar 31, 2026 | 189,000.00 |
| Dec 31, 2025 | 295,000.00 |
| Sep 30, 2025 | 343,000.00 |
| Jun 30, 2025 | 404,000.00 |
| Mar 31, 2025 | 576,000.00 |
| Dec 31, 2024 | 694,000.00 |
| Sep 30, 2024 | 809,000.00 |
| Jun 30, 2024 | 895,000.00 |
| Mar 31, 2024 | 680,000.00 |
| Dec 31, 2023 | 694,000.00 |
| Sep 30, 2023 | 715,000.00 |
| Jun 30, 2023 | 765,000.00 |
| Mar 31, 2023 | 654,000.00 |
| Dec 31, 2022 | 682,000.00 |
| Sep 30, 2022 | 276,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 325,000.00 |
| Dec 31, 2021 | 392,000.00 |
| Sep 30, 2021 | 464,000.00 |
API Access
In8Bio Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=INAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();